Analysts: MRK stock price target of 95 in 12 months

Roman Campbell

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Merck & Co Inc shares valued at $616,395 were sold by Downing Cristal N on Nov 10 ’25. At $87.00 per share, Downing Cristal N sold 7,085 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.

Also, CRISTAL DOWNING purchased 7,085 shares, netting a total of over 616,395 in proceeds.

Before that, Williams David Michael had sold 8,614 shares from its account. In a trade valued at $720,040, the EVP,Chief Info&Digital Officer traded Merck & Co Inc shares for $83.59 each. Upon closing the transaction, the insider’s holdings decreased to 8,614 shares, worth approximately $2.28 million.

As published in their initiating research note from Scotiabank on November 13, 2025, Merck & Co Inc [MRK] has been a Sector outperform and the price target has been revised to $105. As of September 17, 2025, Berenberg has decreased its “Buy” rating to a “Hold” for MRK. Earlier on May 14, 2025, Citigroup downgraded its rating. Their new recommendation was “a Neutral” for MRK stock which previously was a “a Buy”.

Analyzing MRK Stock Performance

On last trading session, Merck & Co Inc [NYSE: MRK] rose 1.62% to $92.93. The stock’s lowest price that day was $90.9, but it reached a high of $94.26 in the same session. During the last five days, there has been a surge of approximately 8.34%. Over the course of the year, Merck & Co Inc shares have dropped approximately -7.74%. Shares of the company reached a 52-week high of $102.97 on 01/07/25 and a 52-week low of $73.31 on 05/15/25.

Support And Resistance Levels for Merck & Co Inc (MRK)

According to the 24-hour chart, there is a support level at 91.13, which, if violated, would cause prices to drop to 89.34. In the upper region, resistance lies at 94.49. The next price resistance is at 96.06. RSI (Relative Strength Index) is 70.48 on the 14-day chart, showing overbought technical sentiment.

Is Merck & Co Inc subject to short interest?

Stocks of Merck & Co Inc saw a sharp rise in short interest on 2025-10-31 jumping by 0.64 million shares to 25.82 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 25.17 million shares. A jump of 2.48% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.18 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.18.

Which companies own the most shares of Merck & Co Inc (MRK)?

In terms of Merck & Co Inc share price expectations, FactSet research, analysts set an average price target of 95 in the next 12 months, up nearly 3.88% from the previous closing price of $91.45. Analysts anticipate Merck & Co Inc stock to reach 100 by 2025, with the lowest price target being 90. In spite of this, 19 analysts ranked Merck & Co Inc stock as Buy at the end of 2025. On April 22, 2025, Cantor Fitzgerald assigned a price target of “a Neutral” to the stock and initiated coverage with a $85.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.